Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Available on website. Loss of £200k. Reporting period 13 months?
A general cholbiome search
https://www.amazon.co.uk/s?k=cholbiome&i=drugstore&crid=R998HTOM4Y58&sprefix=cholbiome%2Cdrugstore%2C73&ref=nb_sb_noss_2
however how many people are aware of cholbiome and therefore search for same?
cholesterol gives
https://www.amazon.co.uk/s?k=cholesterol&i=drugstore&crid=QUUNB0NZ4TQ&sprefix=cholesterol%2Cdrugstore%2C79&ref=nb_sb_noss_1
with at least Cholbiomebp up there at moment though none of the others
just doodling this evening
mol
Https://www.amazon.co.uk/dp/B0BPSW3ZR7/ref=as_li_ss_tl?SubscriptionId=AKIAJO7E5OLQ67NVPFZA&ascsubtag=897648026-192-&tag=msnukrfre-21
Would that be Mikkel's spouse posting under the very good reviews at the bottom of page?
mol
Cheers martinu
I'm not overly impressed with nutritunes website though
https://www.nutritunes.com/
nor have i found this new product on amazon as yet
but yet another new product
mol
Oops try this:
https://www.linkedin.com/feed/update/urn:li:activity:7073947711284080640
Very sad to see OPTI being hammered, should be some news very soon here me thinking, whether it will do anything for the SP gods knows
Very quiet on this partner recently.
These shares are hilarious; at some point they will either be worthless or god forbid they might make some money and they'll have to re-rate by getting them on AIM and off this POS listing.
i would definitely buy at this sp but can't be ****d with going through a broker. especially that it wouldn't be sizeable purchases.
Further promotion here 23 May 2023
https://microbiomepost.com/pre-hypertension-from-biofarma-group-a-nutraceutical-solution-to-counteract-it/
albeit basically what is on Biofarma's website
mol
Evening martinu
Agreed re opti banner and not pbx - mind SOH is known for obfuscation on occasion
that is why i scuttled off to our 2018 rns and noted the similarities
mind i did recheck akums blog release re date and it did note 2023 - even the admin version - and it did say may 2023
albeit i didn't check the behind the scenes property tab of said page
Perhaps somebody who is registered for tomorrow can ask in addition to the apparently newly formed co with Steen as ceo and pbx as owner
mol
Mol, thanks for posting. A bit confusing that it is under the Opti banner and not PBX. If it is new news, will depend on revenues as to whether it is good news. Sounds promising on the face of it.
Mind the wording is similar to our May 2018 release
https://optibiotix.com/optibiotix-signs-agreement-with-akums-at-vitafoods-2018/
mol
May 15, 2023 | Nutraceuticals
Akums with Opti Biotix Health Plc.
Opti Biotix Health Plc., a foremost life sciences group paying attention on harnessing the control of human being micro biome inflection to undertake fatness, high cholesterol and diabetes, has signed a five-year agreement with top pharma contract manufacturers in India Akums Drugs and Pharmaceuticals Ltd.
The conformity, finalized at Vita Foods Europe, held in Geneva, permits Akums the privileges to entirely produce and supply goods containing Opti Biotix’s upcoming-generation probiotic strain for cardiovascular health, LPLDL®, in India. This is a planned step to add production to the supply chain in the Asian probiotic supplements and pharmaceuticals markets and extends the marketable reach of LPLDL® into Southern Asia.
Stephen O’Hara, Opti Biotix CEO, profoundly mentioned that they are thrilled to be associated with Akums, which will broaden access to our pioneering probiotic product LPLDL®. Opti Biotix will be able to proffer manifold product solutions to customer fitness and pharmaceutical companies across the Asian region.
Akums is the major contract manufacturing pharma company in India for food supplements and pharmaceuticals and they were overwhelmed with the wide-ranging familiarity in developing products for many eminent worldwide food and pharmaceutical organizations. This exhilarating joint venture will combine Opti Biotix’s proficiency in micro biome modulation with Akum’ s built-up capacity and range to deliver the genuine, computable health benefits of. LPLDL® is Opti Biotix’s ground-breaking next-generation probiotic product which uses a naturally going on bacterial strain, Lactobacillus plant arum, to decrease cholesterol and assist administration of other cardiovascular biomarkers counting high blood pressure. Self-governing human studies have revealed LPLDL® to be secure and effectual and able to decrease LDL, whole cholesterol and blood pressure.
Akums is the prime contract manufacturing firm in India and is the production associate of option for more than 600 companies in the pharmaceutical and food supplement markets. The firm offers more than 3,500 formulations across key health areas, including cardiovascular disease, providing more than 12% of all food and drug supplements consumed in India.
https://www.akums.in/top-3-reasons-to-hire-a-probiotic-contract-manufacturer/
mol
Well there are a couple of questions that need to be asked on the q&a.
And of course news re
Probiotix Health Denmark ApS
as it has now fallen off the default 25 messages on lse bb
seemingly a new company registered 23 Jan 2023 in Denmark with Steen as sole Director and owned by us
https://ownr-dk.translate.goog/companies/public-profile/43827774?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
with its purpose
The purpose of the company
The company's purpose is to offer consultancy services linked to digital learning solutions and to sell digital learning platforms.
not sure what that has to do with us!
another link
https://vismarating.dk/firma/43827774-probiotix-health-denmark-aps?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
translation of blurb at outset
The company Probiotix Health Denmark ApS is in the industry "Consulting support regarding information technology" and has an address in Søborg. They were established on 23 January 2023 and are of the company type Anpartsselskab.
mol
We were advised that
A detailed trading update will be provided in the next few months - we are of course well into next few...........
Never mind that - audited accounts
First accounts made up to 31 December 2022 - due by 30 June 2023
so not long to wait for audited accounts and presumably a post 31 dec 2022 update
mol
Not just articles but the undernoted recent (Feb23) pdf from lpldl.com website
https://lpldl.com/wp-content/uploads/2023/02/ProBiotix-CholbiomeCH-brochure-232807.pdf
i can understand that probiotix used opti website for online sales initially and continue to do so to keep costs to a minimum (mind there is probably a inter-company recharge ) but about time to move on methinks to avoid confusion and let Steen either prove SOH's only successful hire or otherwise
I also note it is probiotix health ltd and not the plc (at https://probiotixhealth-ir.com/ ) in the pdf and contact lpldl@optibiotix.com for further info
mind the plc site hasn't updated their product portfolio to include cholbiomeCH
https://probiotixhealth-ir.com/about-us/probiotix-products
SOH obviously still has his handprint all over the separately listed plc (albeit on aquis)
mol
For those who prefer not to click links
Abstact
Premium Bioactive Ingredients
Patented lactic acid bacteria strain: Lactobacillus plantarum LP LDL®
Gently freeze-dried to preserve the viability of the bacteria and essential metabolites
Lactobacillus plantarum LP LDL® is characterised by its exceptional enzymatic activity
Combined with vitamin B1 as thiamine HCL
Supplemented with guar gum Sunfiber®️
Hydrolysed guar gum Sunfiber®️ from the Indian guar bean
Food source for bifido- and lactobacteria
How are we different?
When selecting our raw materials, we made sure to use highly active bacterial strains. These are synthesised under strictly controlled conditions using modern fermentation methods that prevent contact with genetically modified bacterial strains, which are often found in other products on the market to keep production costs low.
Our Flora Cardio is composed of special lactic acid bacterial strain, Lactobacillus plantarum LPLDL, as well as vitamin B1 as thiamine HCL and dietary fibre. These bacteria are cultivated under standardised and controlled conditions. The first two fermentation processes are followed by purification and gentle freeze-drying to ensure optimal preservation of the viability of the lactic acid bacteria and preservation of the essential metabolic products. This specially selected Lactobacillus strain is characterised by its exceptional enzymatic activity. The added maltodextrin serves as a nutritional basis for the living bacteria. Microcrystalline cellulose is used as a carrier in this product, which allows a more precise dosage of the fine powder.
We consciously combine the lactic acid bacteria with our vitamin B1 for healthy heart function, nervous system function, energy metabolism and brain function. This blend is supplemented with hydrolysed guar gum Sunfiber®️ from the Indian guar bean. The dietary fibres serve as a food source for bifido and lactobacteria.
For the capsule shells we use custom-made HPMC capsules that, unlike most other HPMC and pullulan capsules on the market, are 100% free from controversial additives such as carrageenans and PEG. We then package this product in environmentally friendly amber glass.
mol
Whilst i have still to find that lpldl has passed anvisa
ayalla are presenting at an upcoming summit
Check out our face-to-face lecture on “The risks of Cardiometabolic Syndrome and the benefits of dietary supplementation in preventing the development of cardiovascular complications” on 05/31 at 11:30 am at NIS Application Trends.
The lecture will bring data on the incidence of Cardiometabolic Syndrome, highlighting the risk factors involved in this process, the implications they may have for the health of the population and how food supplementation can contribute and bring benefits, which help in the control of the Syndromes Metabolic and in preventing the development of cardiovascular complications.
Some ingredients that present scientific literature that prove and highlight the benefits of food supplementation for the control of Cardiometabolic Syndrome will be highlighted, aiming to be a very effective alternative for the reduction of complications and incidence of potential cases for cardiovascular risk factors.
https://nisummit.com.br/en/inicio-2/
mol
Https://www.sunday.de/en/flora-cardio-capsules.html
things seem to be picking up - with CholbiomeCH, Denk Ingredients, Cholerice and Tensred Plus in recent weeks
mol
I, too, have noticed PBX almost operating together with Opti. In some ways it may make economic sense. But why split?
Https://nutraceuticalbusinessreview.com/news/article_page/New_ingredient_from_ProBiotix_supports_companies_making_the_switch_from_Monacolin_K/208777
Interesting that they reference company: OptioBiotix at the end of the article and not ProBiotix
In response to the Monacolin K discussion previously on this BB
To support food brands, retailers and consumers in making the switch from Monacolin K to another alternative solution, CholBiome®CH. contains two active ingredients in a bi-layer tablet – the company’s patented probiotic backed by multiple independent studies, Lactobacillus plantarum LPLDL®, and Plant Sterols / Stanols (PSS). These combine synergistically to support the reduction of both internal and dietary cholesterol levels via its dual action cholesterol reducing formula.
https://optibiotix.com/probiotix-health-launches-cholbiomech-at-vitafoods-europe/?utm_source=twitter&utm_medium=social&utm_campaign&utm_content=ap_tr3ap9n9ih
Steen commented
This new allergen and GMO-free innovation delivers a dual mechanism of action, where the award-winning ingredient LPLDL acts on the internal cholesterol to produce enzymes that break down bile salts. This encourages the liver to remove cholesterol from the blood to replenish required levels and maintain the body’s bile salt pool. Through the secondary action, PSS reduces dietary cholesterol absorption and promotes excretion.
Due to the inclusion of PSS, CholBiome®CH can claim to contribute to the maintenance of normal blood cholesterol levels, as backed by EFSA4.
“High levels of cholesterol have been commonly tackled by approaches that come with multiple undesirable side effects,” continued Andersen. “Yet LPLDL offers a scientific, side-effect free alternative to improve cardiovascular health. The naturally occurring probiotic strain has demonstrated its efficacy in several human studies showing that it can effectively lower total cholesterol and ‘bad’ LDL cholesterol, while increasing ‘good’ HDL cholesterol. As a leader in the microbiome modulation area, consumers and those in the industry can rest assured that we continuously expand the clinical studies supporting the efficacy of CholBiome and LPLDL.”
mol